CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 75 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $495 | -50.5% | 4,479 | 0.0% | 0.00% | -100.0% |
Q3 2022 | $1,000 | 0.0% | 4,479 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $1,000 | -50.0% | 4,479 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $2,000 | -33.3% | 4,479 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $3,000 | -40.0% | 4,479 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $5,000 | -37.5% | 4,479 | 0.0% | 0.00% | -33.3% |
Q2 2021 | $8,000 | -11.1% | 4,479 | 0.0% | 0.01% | -14.3% |
Q1 2021 | $9,000 | -25.0% | 4,479 | -55.1% | 0.01% | -30.0% |
Q4 2020 | $12,000 | -33.3% | 9,980 | 0.0% | 0.01% | -37.5% |
Q3 2020 | $18,000 | -78.6% | 9,980 | 0.0% | 0.02% | -82.6% |
Q2 2020 | $84,000 | +61.5% | 9,980 | 0.0% | 0.09% | +46.0% |
Q1 2020 | $52,000 | – | 9,980 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 5,045,870 | $6,307,000 | 4.30% |
ETF MANAGERS GROUP, LLC | 8,103,641 | $10,130,000 | 0.22% |
AdvisorShares Investments LLC | 271,873 | $340,000 | 0.08% |
Platform Technology Partners | 60,000 | $75,000 | 0.04% |
PINNACLE ASSOCIATES LTD | 942,079 | $1,178,000 | 0.02% |
HRT FINANCIAL LP | 883,510 | $1,104,000 | 0.02% |
Virtu Financial LLC | 153,908 | $192,000 | 0.02% |
Tekla Capital Management LLC | 413,481 | $517,000 | 0.02% |
Aries Wealth Management | 23,400 | $33,000 | 0.02% |
IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 56,932 | $71,000 | 0.02% |